(Q46417608)

22 December 2017

title

Aberration of p73 promoter methylation in de novo myelodysplastic syndrome (English)

1 reference

22 December 2017

author name string

Youshan Zhao

1

1 reference

22 December 2017

Shucheng Gu

2

1 reference

22 December 2017

Juan Guo

3

1 reference

22 December 2017

Zheng Zhang

4

1 reference

22 December 2017

Xi Zhang

5

1 reference

22 December 2017

Xiao Li

6

1 reference

22 December 2017

Chunkang Chang

7

1 reference

22 December 2017

publication date

1 September 2012

1 reference

22 December 2017

published in

Hematology

1 reference

22 December 2017

volume

17

1 reference

22 December 2017

issue

5

1 reference

22 December 2017

page(s)

275-282

1 reference

22 December 2017

The myelodysplastic syndrome(s): a perspective and review highlighting current controversies

cites work

1 reference

https://api.crossref.org/works/10.1179%2F1607845412Y.0000000018

Myelodysplastic syndromes: the complexity of stem-cell diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845412Y.0000000018

Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845412Y.0000000018

DNA methylation as a therapeutic target in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845412Y.0000000018

Gene silencing in cancer in association with promoter hypermethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845412Y.0000000018

Aberrant DNA methylation is a dominant mechanism in MDS progression to AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845412Y.0000000018

Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845412Y.0000000018

p73 induces apoptosis by different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845412Y.0000000018

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845412Y.0000000018

RETRACTED: Alteration of p73 in acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845412Y.0000000018

Epigenetic differences in cytogenetically normal versus abnormal acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845412Y.0000000018

Decitabine activates specific caspases downstream of p73 in myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845412Y.0000000018

Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845412Y.0000000018

Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845412Y.0000000018

Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845412Y.0000000018

The World Health Organization (WHO) classification of the myeloid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845412Y.0000000018

DeltaTAp73 upregulation correlates with poor prognosis in human tumors: putative in vivo network involving p73 isoforms, p53, and E2F-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845412Y.0000000018

Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845412Y.0000000018

Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845412Y.0000000018

Aberrant methylation of death-associated protein kinase 1 CpG islands in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845412Y.0000000018

5-Aza-2'-deoxycytidine induces p21WAF expression by demethylation of p73 leading to p53-independent apoptosis in myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845412Y.0000000018

Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845412Y.0000000018

Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845412Y.0000000018

Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845412Y.0000000018

Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845412Y.0000000018

Methylation status of fragile histidine triad (FHIT) gene and its clinical impact on prognosis of patients with myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845412Y.0000000018

Clinical implications of SOCS1 methylation in myelodysplastic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845412Y.0000000018

DNA methylation predicts survival and response to therapy in patients with myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845412Y.0000000018

Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1607845412Y.0000000018

10.1179/1607845412Y.0000000018

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017